Scott Chianti
Senior Vice President and Chief Financial Officer
Replay available
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

Senior Vice President and Chief Financial Officer
Senior Vice President and Chief Medical Officer
Chief Executive Officer and Director
SVP Investor Relations and Corporate Communications
Watch the replay and follow the connected company analysis, news, and investor updates for Lexicon Pharmaceuticals, Inc..
WEBVTT 00:00:01.583 -- 00:00:06.788 Welcome to the Lexicon for Missouri Coast First Quarter 2026 Financial Results Conference 00:00:06.788 -- 00:00:11.393 Call. At this time, all participants are in listen-only mode. 00:00:11.393 -- 00:00:16.238 Following management's preferred remarks, we will hold a brief question-and-answer session. 00:00:16.238 -- 00:00:20.282 As a reminder, this call is being recorded today, May 7, 2026. 00:00:20.282 -- 00:00:25.627 I will now turn the call over to Lisa DeFrancesco, SBP Investor Relations 00:00:25.627 -- 00:00:30.470 and Corporate Communications for Lexicon. Please go ahead, Lisa. 00:00:30.676 -- 00:00:35.501 Thank you, Tricia. Good morning, and welcome to our first quarter 2026 earnings call. 00:00:35.501 -- 00:00:40.086 Joining me today are Dr. Mike Exton, Lexicon's Chief Executive Officer and Director, 00:00:40.086 -- 00:00:44.832 Dr. Craig Granowitz, Senior Vice President and Chief Medical Officer, and Scott Chianti, 00:00:44.832 -- 00:00:47.595 Senior Vice President and Chief Financial Officer. 00:00:47.595 -- 00:00:51.098 This morning, Lexicon issued a press release announcing our financial results for the 00:00:51.098 -- 00:00:56.502 first quarter of 2026, which is available on our website at www.lexfarmer.com 00:00:56.765 -- 00:01:01.264 and through our RCC filings. A webcast of this call, along with a slide presentation, 00:01:01.264 -- 00:01:05.928 is also available on our website. During this call, we will review the information provided 00:01:05.928 -- 00:01:09.452 in the release, provide a corporate update, and then use the remainder of our time to 00:01:09.452 -- 00:01:13.896 answer your questions. Before we begin, let me remind you that we will be making forward-looking 00:01:13.896 -- 00:01:18.220 statements, inc...